Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Sales: 2009-2020

Historic Return on Sales for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Dec 2020 value amounting to 1.35%.

  • Avadel Pharmaceuticals' Return on Sales rose 263.00% to 1.35% in Q4 2020 from the same period last year, while for Dec 2020 it was 1.35%, marking a year-over-year increase of 263.00%. This contributed to the annual value of -0.28% for FY2020, which is 100.00% up from last year.
  • According to the latest figures from Q4 2020, Avadel Pharmaceuticals' Return on Sales is 1.35%, which was up 284.87% from -0.73% recorded in Q3 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Return on Sales registered a high of 1.35% during Q4 2020, and its lowest value of -1.36% during Q3 2019.
  • Its 3-year average for Return on Sales is -0.61%, with a median of -0.83% in 2018.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Return on Sales soared by 1,660bps in 2016, and later tumbled by 134bps in 2019.
  • Avadel Pharmaceuticals' Return on Sales (Quarterly) stood at -0.27% in 2016, then surged by 67bps to 0.39% in 2017, then crashed by 132bps to -0.92% in 2018, then crashed by 36bps to -1.28% in 2019, then skyrocketed by 263bps to 1.35% in 2020.
  • Its last three reported values are 1.35% in Q4 2020, -0.73% for Q3 2020, and -0.40% during Q2 2020.